Study Stopped
Change of Institutional Affliation \& Funding Changes
Sorbent Treatment Prescriptions Pilot Study
Sorb2
Hemodialysis With the 2008 Sorbent System: A Pilot Evaluation of Different Treatment Prescriptions
1 other identifier
observational
12
1 country
1
Brief Summary
This study will compare how well blood of renal failure patients is cleaned with the new 2008 Sorbent System using two different dialysate speeds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 19, 2011
CompletedFirst Posted
Study publicly available on registry
September 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedApril 12, 2017
April 1, 2017
3 months
September 19, 2011
April 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Treatment Adequacy
spKt/V, eKt/V, and Std Weekly Kt/V (Kt/V = dialysis adequacy)
4 weeks
Study Arms (1)
2008 Sorbent system
Hemodialysis with the 2008 Sorbent system
Interventions
2008 Sorbent System with dialysate flow rates (Qd) of 400 and 500 ml/min while maintaining a constant blood flow rate (Qb) and constant dialyzer (KoA).
Eligibility Criteria
End-stage renal disease patients
You may qualify if:
- age \</=18 years
- end-stage renal disease (ESRD) patient on chronic high-flux hemodialysis for \</= 6 months at time of enrollment
- well-functioning fistula, graft or catheter as hemodialysis access, achieving blood flow rates of \>/= 300 mL/min
- ability to understand the English language
You may not qualify if:
- Pre-dialysis serum blood urea nitrogen (BUN) concentration below 30 mg/dL in the last three months
- Severe Coronary Heart Disease or Heart Failure (New York Heart Association class IV)
- Active Infections
- Hepatitis B
- Any other active infection that has required antibiotic treatment in the preceding eight weeks
- Pre-study lab values of any of the following (in the most recent routine lab work)
- Sodium - Na+ \> 150 mmol/L, Na+ \< 132 mmol/L
- Potassium - K+ \> 6.5 mmol/L, K+ \< 3.5 mmol/L
- Total Calcium - Ca \> 12 mg/dL (3 mmol/L), total Ca \< 7.2 mg/dL (1.8 mmol/L)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Renal Research Institutelead
- Renal Solutions, Inc.collaborator
Study Sites (1)
Yorkville Dialysis Center
New York, New York, 10128, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Kotanko, MD
Renal Research Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2011
First Posted
September 21, 2011
Study Start
August 1, 2011
Primary Completion
November 1, 2011
Study Completion
January 1, 2012
Last Updated
April 12, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share